IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection

We investigated the dynamics of seroconversion in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. During March 29-May 22, 2020, we collected serum samples and associated clinical data from 177 persons in London, UK, who had SARS-CoV-2 infection. We measured IgG against SARS-CoV-2 and compared antibody levels with patient outcomes, demographic information, and laboratory characteristics. We found that 2.0%-8.5% of persons did not seroconvert 3-6 weeks after infection. Persons who seroconverted were older, were more likely to have concurrent conditions, and had higher levels of inflammatory markers. Non-White persons had higher antibody concentrations than those who identified as White; these concentrations did not decline during follow-up. Serologic assay results correlated with disease outcome, race, and other risk factors for severe SARS-CoV-2 infection. Serologic assays can be used in surveillance to clarify the duration and protective nature of humoral responses to SARS-CoV-2 infection.

Citing Articles

Detection of SARS-CoV-2 and a possible variant in shelter cats.

Okwumabua O, Bradley-Siemens N, Cruz C, Chittick L, Thompson M PLoS One. 2025; 20(1):e0317104.

PMID: 39804893 PMC: 11730420. DOI: 10.1371/journal.pone.0317104.

Longitudinal determination of seroprevalence and immune response to SARS-CoV-2 in a population of food and retail workers through decentralized testing and transformation of ELISA datasets.

Djaileb A, Parker M, Lavallee E, Stuible M, Durocher Y, Theriault M PLoS One. 2024; 19(12):e0314499.

PMID: 39680559 PMC: 11649073. DOI: 10.1371/journal.pone.0314499.

High prevalence of SARS-CoV-2 antibodies and low prevalence of SARS-CoV-2 RNA in cats recently exposed to human cases.

Daigle L, Khalid H, Gagnon C, Arsenault J, Bienzle D, Bisson S BMC Vet Res. 2024; 20(1):304.

PMID: 38982461 PMC: 11232172. DOI: 10.1186/s12917-024-04150-4.

Impact of SARS-CoV-2 Infection on Maternal and Neonatal Outcome in Correlation with Sociodemographic Aspects: A Retrospective Case-Control Study.

Chicea R, Neagu A, Chicea E, Grindeanu A, Bratu D, Boicean A J Clin Med. 2023; 12(19).

PMID: 37834966 PMC: 10573086. DOI: 10.3390/jcm12196322.

Persistence of SARS-CoV-2 IgG Antibody Response among South African Adults: A Prospective Cohort Study.

Adeniyi O, Durojaiye O, Masilela C Vaccines (Basel). 2023; 11(6).

PMID: 37376457 PMC: 10302206. DOI: 10.3390/vaccines11061068.

References

Long Q, Liu B, Deng H, Wu G, Deng K, Chen Y . Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020; 26(6):845-848. DOI: 10.1038/s41591-020-0897-1. View

Ruan Q, Yang K, Wang W, Jiang L, Song J . Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5):846-848. PMC: 7080116. DOI: 10.1007/s00134-020-05991-x. View

Zhu F, Li Y, Guan X, Hou L, Wang W, Li J . Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020; 395(10240):1845-1854. PMC: 7255193. DOI: 10.1016/S0140-6736(20)31208-3. View

Kucirka L, Lauer S, Laeyendecker O, Boon D, Lessler J . Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure. Ann Intern Med. 2020; 173(4):262-267. PMC: 7240870. DOI: 10.7326/M20-1495. View

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H . Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8(5):475-481. PMC: 7102538. DOI: 10.1016/S2213-2600(20)30079-5. View

Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y . Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019. Clin Infect Dis. 2020; 71(16):2027-2034. PMC: 7184337. DOI: 10.1093/cid/ciaa344. View

Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View

Xie C, Jiang L, Huang G, Pu H, Gong B, Lin H . Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests. Int J Infect Dis. 2020; 93:264-267. PMC: 7129110. DOI: 10.1016/j.ijid.2020.02.050. View

Fafi-Kremer S, Bruel T, Madec Y, Grant R, Tondeur L, Grzelak L . Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France. EBioMedicine. 2020; 59:102915. PMC: 7502660. DOI: 10.1016/j.ebiom.2020.102915. View

10.

Guo L, Ren L, Yang S, Xiao M, Chang D, Yang F . Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Clin Infect Dis. 2020; 71(15):778-785. PMC: 7184472. DOI: 10.1093/cid/ciaa310. View

11.

Jiang S, Hillyer C, Du L . Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses. Trends Immunol. 2020; 41(5):355-359. PMC: 7129017. DOI: 10.1016/j.it.2020.03.007. View

12.

Xu X, Han M, Li T, Sun W, Wang D, Fu B . Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A. 2020; 117(20):10970-10975. PMC: 7245089. DOI: 10.1073/pnas.2005615117. View

13.

Salazar E, Perez K, Ashraf M, Chen J, Castillo B, Christensen P . Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma. Am J Pathol. 2020; 190(8):1680-1690. PMC: 7251400. DOI: 10.1016/j.ajpath.2020.05.014. View